Ambiente
Stora Enso's fourth quarter 2023 impairment test results
The impairment charges are allocated between the segments as follows:
Packaging Materials
26
355
Biomaterials
45
58
Wood Products
—
15
Other
—
15
The fixed asset impairments in the Packaging Materials division mainly relate to the Business Unit Containerboard and in the Biomaterials division to the Nordic production units. The impairments are mainly a consequence of Stora Enso's predictions of a weaker outlook compared to previous estimates.
As a result of the impairment booking, the annual depreciation will decrease by approximately EUR 40 million going forward. The impairments do not impact Stora Enso's full-year 2023 guidance.
Anna-Lena Åström
SVP Investor Relations
tel. +46 70 210 7691
Part of the global bioeconomy, Stora Enso is a leading provider of renewable products in packaging, biomaterials and wooden construction, and one of the largest private forest owners in the world. We believe that everything that is made from fossil-based materials today can be made from a tree tomorrow. Stora Enso has approximately 21,000 employees and our sales in 2022 were
EUR 11.7 billion . Stora Enso shares are listed on Nasdaq Helsinki Oy (STEAV, STERV) and Nasdaq Stockholm AB (STE A, STE R). In addition, the shares are traded in the
USA as ADRs and ordinary shares (SEOAY, SEOFF, SEOJF). storaenso.com/investors
STORA ENSO OYJ
Anna-Lena Åström
SVP Investor Relations
tel. +46 70 210 7691
View original content:https://www.prnewswire.co.uk/news-releases/stora-ensos-fourth-quarter-2023-impairment-test-results-302012673.html